5:
TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.
Castillejo A, Rothman N, Murta-Nascimento C, Malats N, García-Closas M, Gómez-Martínez A, Lloreta J, Tardón A, Serra C, García-Closas R, Chanock S, Silverman DT, Dosemeci M, Kogevinas M, Carrato A, Soto JL, Real FX.
Int J Cancer. 2009 Feb 1;124(3):608-13.
PMID: 19004027 [PubMed - indexed for MEDLINE]
Related Articles
6:
Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Kaklamani VG, Baddi L, Liu J, Rosman D, Phukan S, Bradley C, Hegarty C, McDaniel B, Rademaker A, Oddoux C, Ostrer H, Michel LS, Huang H, Chen Y, Ahsan H, Offit K, Pasche B.
Cancer Res. 2005 Apr 15;65(8):3454-61. Erratum in: Cancer Res. 2006 Mar 15;66(6):3345.
PMID: 15833881 [PubMed - indexed for MEDLINE]
Related Articles Free article at journal site
9:
TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population.
Jin G, Deng Y, Miao R, Hu Z, Zhou Y, Tan Y, Wang J, Hua Z, Ding W, Wang L, Chen W, Shen J, Wang X, Xu Y, Shen H.
J Cancer Res Clin Oncol. 2008 Mar;134(3):345-51. Epub 2007 Aug 7.
PMID: 17680270 [PubMed - indexed for MEDLINE]
Related Articles
11:
Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers.
Jin Q, Hemminki K, Grzybowska E, Klaes R, Söderberg M, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Pamula J, Pekala W, Försti A.
Int J Cancer. 2004 Oct 20;112(1):94-9.
PMID: 15305380 [PubMed - indexed for MEDLINE]
Related Articles